
enVVeno Medical
(NASDAQ) NVNO
enVVeno Medical Financials at a Glance
Market Cap
$6.64M
Revenue (TTM)
$0.00
Net Income (TTM)
$19.47M
EPS (TTM)
$-33.05
P/E Ratio
-0.31
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$10.14
Volume
637
Open
$10.14
Price
$10.14
Volume
637
Open
$10.14
Previous Close
$10.14
Daily Range
$10.14 - $10.14
52-Week Range
$8.67 - $196.70
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$10.14
Volume
637
Open
$10.14
Previous Close
$10.14
Daily Range
$10.14 - $10.14
52-Week Range
$8.67 - $196.70
NVNO News
NVNO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout enVVeno Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
33
CEO
Robert Andrew Berman
Website
www.envveno.comHeadquarters
Irvine, CA 92618, US
NVNO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-56%
Return on Capital
-76%
Return on Assets
-66%
Earnings Yield
-3.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.64M
Shares Outstanding
655.50K
Volume
637
Short Interest
0.00%
Avg. Volume
21.59K
Financials (TTM)
Gross Profit
$489.00K
Operating Income
$20.90M
EBITDA
$20.41M
Operating Cash Flow
$15.57M
Capital Expenditure
$5.00K
Free Cash Flow
$15.57M
Cash & ST Invst.
$28.21M
Total Debt
$700.00K
enVVeno Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$117.00K
+4.1%
Gross Margin
0.00%
N/A
Market Cap
$6.64M
N/A
Market Cap/Employee
$179.47K
N/A
Employees
37
N/A
Net Income
$3.74M
+40.0%
EBITDA
$5.05M
+17.4%
Quarterly Fundamentals
Net Cash
$27.51M
-34.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$310.00K
-55.7%
Short Term Debt
$390.00K
+7.1%
Return on Assets
-65.87%
N/A
Return on Invested Capital
-76.16%
N/A
Free Cash Flow
$3.44M
+32.6%
Operating Cash Flow
$3.44M
+32.6%